Lv1
90 积分 2023-06-20 加入
吸入三联药物的研究现状及展望
1个月前
已完结
Modified-Release Drug Delivery Technology
4个月前
已完结
Synthesis and in vitro biological evaluation of 3-ethyl-1,5-naphthyridin-2(1H)-one derivatives as potent PARP-1 selective inhibitors and PARP-1 DNA trappers
5个月前
已完结
Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers
5个月前
已完结
皖公网安备34019202002308
